Drug(s) |
Dose and route |
Comments |
Acepromazine (A) + Opioid (one of the following): Butorphanol (B) or Buprenorphine (Bu) or Methadone (Me) |
0.03–0.05 mg/kg i.m. (A) + 0.2–0.4 mg/kg i.m. (B) or 20 μg/kg i.m. (Bu) or 0.2–0.5 mg/kg i.m. (Me) |
Commonly used combination in adult dogs In puppies, the acepromazine may predispose to prolonged recovery and hypothermia Morphine does not have marketing authorization |
Medetomidine (M) + Opioid (one of the following): Butorphanol (B) or Buprenorphine (Bu) or Methadone (Me) |
10–20 μg/kg i.m. (M) + 0.2–0.4 mg/kg i.m. (B) or 20 μg/kg i.m. (Bu) or 0.1–0.2 mg/kg i.m. (Me) |
Provides profound sedation Medetomidine can be reversed with atipamezole The medetomidine + methadone combination will necessitate reduced doses of induction agent a, such as:
|
Midazolam (Mi) + Methadone (Me) |
0.3–0.4 mg/kg i.m. (Mi) + 0.2–0.5 mg/kg i.m. (Me) |
Midazolam does not have marketing authorization |
Dexmedetomidine (D) + Opioid (one of the following): Butorphanol (B) + Buprenorphine (Bu) + Methadone (Me) |
125–375 μg/m2 i.m. (D) + 0.1–0.4 mg/kg i.m. (B) or 10–20 μg/kg i.m. (Bu) or 0.1–0.2 mg/kg i.m. (Me) |
Provides profound sedation Body surface area formula ensures accuracy of dosing across a range of sizes of dog Dexmedetomidine can be reversed with atipamezole The dexmedetomidine + methadone combination will necessitate reduced doses of induction agent a, such as:
|
Midazolam/diazepam (Mi/D) + Ketamine (K) |
0.25–0.5 mg/kg i.m., i.v. (Mi/D) + 5–10 mg/kg i.m., i.v. (K) |
Expect profound sedation/light general anaesthesia Use lower doses i.v. |